1510 related articles for article (PubMed ID: 8923851)
1. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
3. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
[TBL] [Abstract][Full Text] [Related]
5. Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle.
Stouffer RL; Dahl KD; Hess DL; Woodruff TK; Mather JP; Molskness TA
Biol Reprod; 1994 Apr; 50(4):888-95. PubMed ID: 8199268
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat.
Woodruff TK; Krummen LA; Lyon RJ; Stocks DL; Mather JP
Endocrinology; 1993 Jun; 132(6):2332-41. PubMed ID: 8504739
[TBL] [Abstract][Full Text] [Related]
7. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
MacNaughton J; Banah M; McCloud P; Hee J; Burger H
Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
[TBL] [Abstract][Full Text] [Related]
8. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.
Suresh PS; Medhamurthy R
Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529
[TBL] [Abstract][Full Text] [Related]
10. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
11. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
[TBL] [Abstract][Full Text] [Related]
12. Stress and the menstrual cycle: short- and long-term response to a five-day endotoxin challenge during the luteal phase in the rhesus monkey.
Xiao E; Xia-Zhang L; Ferin M
J Clin Endocrinol Metab; 1999 Feb; 84(2):623-6. PubMed ID: 10022427
[TBL] [Abstract][Full Text] [Related]
13. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
[TBL] [Abstract][Full Text] [Related]
14. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
15. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
[TBL] [Abstract][Full Text] [Related]
16. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
17. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
18. Stress and the menstrual cycle: relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey.
Xiao E; Xia-Zhang L; Barth A; Zhu J; Ferin M
J Clin Endocrinol Metab; 1998 Jul; 83(7):2454-60. PubMed ID: 9661628
[TBL] [Abstract][Full Text] [Related]
19. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and not central suppression of ovarian function during osmotic pump infusion of adrenocorticotropin-(1-24) for one menstrual cycle in the cynomolgus monkey and its partial compensation by a transitory elevation of sex hormone-binding globulin levels.
Kowalski W; Chatterton RT
Endocrinology; 1992 Jun; 130(6):3582-92. PubMed ID: 1597155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
